Company Data
Gain Therapeutics Inc.
Ticker
GANX
Current Price
$1.77 -1.67%
Market Cap
$52.3M
Price Target
Refer to Report
Volume
157.1K
52wk Range
$0.89 - $3.19
Overview
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders and oncology. The company has filed four patent applications for novel small molecule drug candidates that are Structurally Targeted Allosteric Regulators (STARs). The company derives revenues from collaboration and licensing agreements.